StockIQStockIQ.tech
Account
Register Login

McKesson Corporation (MCK) Stock Analysis

--

Free AI-powered analysis and research for McKesson Corporation stock

Sector: Healthcare

MCK snapshot

Data as of 9 Oct 2026 close. Updated daily.

Last close
938.84 USD (+0.92%)
52-week range
723.68 – 999.00
Position in range
78%
1-year change
+23.0%
Market cap (USD)
$109.5B
P/E (trailing)
24.6
RSI (14-day)
66
vs 200-day average
+10.4%
MACD
Above signal line
StockIQ score: 72/100 · Positive signals

McKesson Corporation scores 72/100 on StockIQ's model, which reads as positive signals overall. The price is above its 200-day average and at 78% of its 52-week range, up 23.0% over the past year. Latest reported figures show a profit margin of 1.1% and revenue growth of +7.7%.

What is driving the score
  • Strong Uptrend: +12
  • MACD Bullish: +8
  • Weak Profit Margin (1.1%): -8
  • Liquidity Crisis (0.89 Current Ratio): -10
  • Low P/B (-25.11): +5
  • Strong Long-term Uptrend: +8
  • Healthy Momentum (+23.0% over 1 year): +7

Automated, general information only – not financial advice. Scores can be wrong. How the score works

Full MCK report

McKesson Corporation (MCK) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.

Analyze MCK Now β†’

πŸ“° Latest Update

McKesson (MCK) Ascends While Market Falls: Some Facts to Note

McKesson (MCK) saw its stock rise despite a broader market decline, reflecting strong investor confidence in the company's fundamentals and growth prospects. This upward movement is significant as it highlights McKesson's resilience in a challenging market environment, potentially indicating robust demand for its healthcare services. Investors may view this as a positive signal for the company's future performance and stability amidst economic fluctuations.

Read full article β†’

History

People also watch

REGN
Regeneron Pharmaceuticals Inc.
--
VRTX
Vertex Pharmaceuticals Inc.
--
ZTS
Zoetis Inc.
--
MIRM
Mirum Pharmaceuticals, Inc.
--
ADPT
Adaptive Biotechnologies Corporation
--